Board to consider Dividend
Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2018, inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2018 and recommend dividend for the financial year 2017-18, if any.Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations,... Board Meeting - Board Meeting On May 29, 2018
Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 29th May, 2018, inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2018 and recommend dividend for the financial year 2017-18, if any.... Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith certificate received from M/s. Gajanan D. Athavale, Practicing Company Secretary, Mumbai for the half year ended 31st March, 2018. Announcement under Regulation 30 (LODR)-Newspaper Publication
Enclosed herewith are the copies of the Newspaper Advertisements published in Free Press Journal (English Edition) and Navshakti (Marathi Edition), relating to notice convening the meeting of the Equity Shareholders of the Company, scheduled to be held on Monday, 28th day of May, 2018, pursuant to the Order dated March 21, 2018 by the National Company Law Tribunal, Mumbai bench Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Intimation of the Notices to Equity Shareholders with respect to the Scheme of Amalgamation (Merger by Absorption) of Gufic Stridden Bio-Pharma Private Limited with Gufic Biosciences Limited Announcement under Regulation 30 (LODR)-Credit Rating
Credit Rating for Long Term Bank facilities availed by the Company Compliance Certificate For The Period Ended March 31, 2018
Kindly find enclosed Compliance Certificate for the period ended March 31, 2018, duly signed by the Compliance Officer and the Authorized Signatory of the Registrar & Transfer Agent, as required under Regulation 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Shareholding for the Period Ended March 31, 2018
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami ShahDesignation :- Company Secretary and Compliance Officer Board Meeting-Outcome of Board Meeting
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., 12th February, 2018, inter alia considered and approved the following items : 1. Un-audited Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2017. Enclosed is the same,...